Navigating tax incentives and changing regulations can be overwhelming. However, the One Big Beautiful Bill Act (OBBBA) has officially rolled back Section 174 capitalization rules. Businesses can once again benefit from full, immediate expensing of domestic research costs, reversing the restrictive amortization requirements of previous years.
Furthermore, R&D credits may generally be claimed on originally filed or amended returns under the standard statute of limitations. Certain retroactive elections created by the 2025 law carried their own separate deadlines; a qualified review can confirm which options remain open to your business.